Skip to content

Faculty profile

Marisa Battistella

Back to faculty
ProfessorUniversity of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

  • Perspectives on Deprescribing Medications Among Patients Receiving Hemodialysis: A Qualitative Study.

    American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026 · senior author

  • Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

    Canadian journal of kidney health and disease · 2026

  • Scoping review of apixaban and rivaroxaban dosing for atrial fibrillation and venous thromboembolism in advanced chronic kidney disease.

    International journal of clinical pharmacy · 2026

All 65 publications

Latest funding

  • Pragmatic randomised trial of High Or Standard PHosphAte Targets in End-stage kidney disease - PHOSPHATE Canada (TARGET 2)

    CIHR · 2018 · Co-investigator

    $1,526,175
  • Strategies for the management of Atrial Fibrillation in patiEnts receiving HemoDialysis (SAFE-HD)

    CIHR · 2018 · Co-investigator

    $314,416
  • A pilot study to evaluate the feasibility and safety of performing a double blind, placebo-controlled, randomized controlled trial of The Routine use of SSRIs at the Initiation of End-stage Renal Disease Treatment (ROSIE)

    CIHR · 2012 · Co-investigator

    $174,168
All 3 grants and awards

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction